USA Rare Earth, Inc. Releases Unaudited Pro Forma Combined Financials Following Major Merger and Capital Events
Key Highlights
- Transformational Merger: USA Rare Earth, Inc. (USAR) has executed a significant merger with SVRE Holdings Ltd. (SVRE), a subsidiary of Serra Verde Rare Earths Ltd. This deal establishes SVRE as a wholly owned subsidiary of USAR, with the merger consideration including an issuance of 126,849,307 USAR shares and \$300 million in cash. The transaction is expected to reshape USAR’s business, increase scale, and potentially alter its market positioning.
- Substantial Private Placement: On January 26, 2026, USAR closed a private placement, issuing 69,767,442 shares at \$21.50 per share, generating approximately \$1.5 billion in gross proceeds. This significantly augments USAR’s capital base and liquidity.
- Potential \$1.6 Billion U.S. Government Funding: USAR has entered non-binding letters of intent with the U.S. Department of Commerce for up to \$1.6 billion in funding, including direct CHIPS Act awards and senior secured debt. Definitive agreements were executed on June 3, 2026, but actual funding remains contingent on achieving certain milestones and government approvals. No related proceeds are included in the current pro forma statements.
- Long-Term Debt Financing (Retained Finance Agreement): SVRE secured a long-term debt facility with the U.S. International Development Finance Corporation (DFC) for up to \$565 million, with \$325 million drawn as of March 31, 2026. This supports the group’s mining and processing operations.
- Strategic Offtake Agreement: SV Management Switzerland AG (a subsidiary of SVRE) signed an offtake agreement with a U.S. government-backed vehicle and private investors for the long-term supply of rare earth materials. The agreement covers 100% of phase one production from the Pela Ema project, with delivery obligations potentially reduced to 75% depending on loan disbursement milestones.
- Issuance of Earnout Shares: USAR issued a total of 10.1 million earnout shares to certain shareholders upon achieving share price milestones (\$15 and \$20 for 20 out of 30 consecutive trading days). The earnout shares were reclassified from liabilities to equity upon issuance, impacting the balance sheet and additional paid-in capital.
Financial Data and Pro Forma Presentation
-
Pro Forma Balance Sheet (as of March 31, 2026):
- Total pro forma assets: \$6.66 billion
- Pro forma cash and equivalents: \$1.56 billion after accounting for merger-related cash outflows
- Significant increases in property, plant & equipment, intangible assets, and goodwill (goodwill: \$1.46 billion)
- Total pro forma liabilities: \$1.66 billion, reflecting debt, royalty obligations, and deferred tax liabilities
- Stockholders’ equity surges to nearly \$5 billion post-transactions
-
Pro Forma Statement of Operations (Three Months Ended March 31, 2026):
- Total pro forma revenue: \$6.3 million
- Net loss attributable to USAR: \$75.1 million, or a loss of \$0.23 per share (333.4 million weighted average shares outstanding)
- Major contributors to the net loss include transaction costs, fair value changes on financial instruments, and interest expenses related to new debt
-
Pro Forma Statement of Operations (Year Ended December 31, 2025):
- Total pro forma revenue: \$4.1 million
- Net loss attributable to USAR: \$460.1 million, or \$1.65 per share (294.6 million weighted average shares outstanding)
- Substantial nonrecurring transaction costs (\$113 million) and fair value adjustments on financial instruments impacted results
Price-Sensitive and Shareholder-Relevant Information
- Massive Capital Infusion: The \$1.5 billion private placement and potential \$1.6 billion in government-backed funding (if milestones are met) dramatically strengthen USAR’s balance sheet and ability to execute on growth plans. However, the government funding is not guaranteed and remains contingent on approvals and milestones.
- Material Transaction Costs and Goodwill: Shareholders should note the significant transaction costs (\$113 million) and the large goodwill recognized (\$1.3–\$2.1 billion depending on share price). Any future impairment of goodwill could negatively affect future earnings.
- Share Dilution: The merger, private placement, and earnout shares will increase the total share count substantially (over 333 million pro forma shares, up from 98 million historically). This dilution could pressure earnings per share and affect valuation metrics.
- Strategic Offtake Agreement: The long-term offtake agreement provides revenue visibility but also creates dependency on a single project (Pela Ema) and specific delivery milestones.
- Execution and Integration Risks: The pro forma financials are based on preliminary estimates, and final purchase price allocation and fair value adjustments may change, impacting future reported results.
- Significant Pro Forma Losses: The pro forma net losses are substantial, driven by transaction-related costs, financing costs, and non-cash charges. Investors should consider the path to profitability as integration and capital deployment proceed.
Conclusion
The series of transactions detailed in this report—including the transformative merger with SVRE, a \$1.5 billion capital raise, and potential access to U.S. government funding—represent a pivotal moment for USA Rare Earth, Inc. The company emerges with a dramatically expanded asset base, enhanced capital resources, and a major strategic offtake agreement. However, the scale of share dilution, significant transaction costs, execution risks, and large pro forma net losses are critical factors for shareholders to monitor. The ultimate impact on share value will depend on the company’s ability to achieve operational milestones, secure government funding, and integrate the new assets and businesses efficiently.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. All forward-looking statements are subject to risks and uncertainties. Investors should review the company’s filings and consult their financial advisors before making investment decisions.
